Ephraim W. Church
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ephraim W. Church has a total of 181 co-authors. Here are the top co-authors by number of shared publications:
- Pratik Rohatgi
Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, Pennsylvania
7 shared publications Emily Sieg
Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, Pennsylvania
6 shared publicationsOmar Zalatimo
Department of Neurosurgery, Penn State Hershey Medical Center
6 shared publicationsRussell Payne
Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, Pennsylvania
6 shared publicationsEinar Bogason
Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, Pennsylvania
5 shared publicationsEndrit Ziu
4 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
Charge Comparison of Standalone Middle Meningeal Artery Embolization to Nonsurgical Medical Management for Chronic Subdural Hematoma: A Propensity Score–Matched Analysis
- 9 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
Open AccessCharge Comparison of Standalone Middle Meningeal Artery Embolization to Nonsurgical Medical Management for Chronic Subdural Hematoma: A Propensity Score–Matched Analysis
- 7 July 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Clopidogrel versus ticagrelor in dual antiplatelet therapy for flow diversion of unruptured intracranial aneurysms: analysis of the Neurovascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) Cerebral Aneurysm Registry
Objectives: To evaluate the safety and efficacy of clopidogrel versus ticagrelor in patients undergoing flow diverting stent (FDS) placement for unruptured intracranial aneurysms (UIAs). Methods: The Neurovascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) Cerebral Aneurysm Registry was queried for patients who underwent FDS placement for UIAs treated with clopidogrel or ticagrelor. Propensity score matching (1:1) was performed to balance demographics, comorbidities, and aneurysm characteristics. Primary outcomes were intraoperative thrombus formation and postoperative symptomatic intracranial hemorrhage (sICH). Secondary outcomes included modified Rankin Scale (mRS), aneurysm occlusion at discharge, and parent vessel stenosis or occlusion on long-term follow-up. Results: 1387 patients (1088 clopidogrel, 299 ticagrelor) were analyzed. Ticagrelor was more frequently used in posterior circulation aneurysms (7.8% clopidogrel vs. 14.4% ticagrelor, P=0.0008) and cases requiring multiple FDS (8.7% clopidogrel vs. 28.2% ticagrelor, P<0.0001). Rates of intraoperative thrombus formation (0.5% clopidogrel vs 0.3% ticagrelor, P=1) and postoperative sICH (0.3% clopidogrel vs 0.5% ticagrelor, P=1) were similar, as were discharge mRS, aneurysm occlusion at discharge, last follow-up mRS, and rates of parent vessel occlusion or stenosis. After matching (180 per group), there were similar rates of intraoperative thrombus formation (0% clopidogrel vs 0.6% ticagrelor, P=1) and postoperative sICH (0.6% clopidogrel vs 0.6% ticagrelor, P=1). Functional outcomes, aneurysm occlusion at discharge, and rates of parent vessel stenosis or occlusion also remained similar. Conclusion: No significant differences in safety or efficacy were detected between clopidogrel and ticagrelor in patients undergoing FDS placement for UIAs.
- 7 July 2026
- Published by BMJ in Journal of NeuroInterventional Surgery
Clopidogrel versus ticagrelor in dual antiplatelet therapy for flow diversion of unruptured intracranial aneurysms: analysis of the Neurovascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) Cerebral Aneurysm Registry
Objectives: To evaluate the safety and efficacy of clopidogrel versus ticagrelor in patients undergoing flow diverting stent (FDS) placement for unruptured intracranial aneurysms (UIAs). Methods: The Neurovascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) Cerebral Aneurysm Registry was queried for patients who underwent FDS placement for UIAs treated with clopidogrel or ticagrelor. Propensity score matching (1:1) was performed to balance demographics, comorbidities, and aneurysm characteristics. Primary outcomes were intraoperative thrombus formation and postoperative symptomatic intracranial hemorrhage (sICH). Secondary outcomes included modified Rankin Scale (mRS), aneurysm occlusion at discharge, and parent vessel stenosis or occlusion on long-term follow-up. Results: 1387 patients (1088 clopidogrel, 299 ticagrelor) were analyzed. Ticagrelor was more frequently used in posterior circulation aneurysms (7.8% clopidogrel vs. 14.4% ticagrelor, P=0.0008) and cases requiring multiple FDS (8.7% clopidogrel vs. 28.2% ticagrelor, P<0.0001). Rates of intraoperative thrombus formation (0.5% clopidogrel vs 0.3% ticagrelor, P=1) and postoperative sICH (0.3% clopidogrel vs 0.5% ticagrelor, P=1) were similar, as were discharge mRS, aneurysm occlusion at discharge, last follow-up mRS, and rates of parent vessel occlusion or stenosis. After matching (180 per group), there were similar rates of intraoperative thrombus formation (0% clopidogrel vs 0.6% ticagrelor, P=1) and postoperative sICH (0.6% clopidogrel vs 0.6% ticagrelor, P=1). Functional outcomes, aneurysm occlusion at discharge, and rates of parent vessel stenosis or occlusion also remained similar. Conclusion: No significant differences in safety or efficacy were detected between clopidogrel and ticagrelor in patients undergoing FDS placement for UIAs.
- Open Access
- 6 February 2026
- Published by Elsevier in World Neurosurgery
- Vol. 208, 124845
Microsurgical Treatment of Ethmoidal Dural Arteriovenous Fistula
- 6 February 2026
- Published by Elsevier in World Neurosurgery
- Vol. 208, 124845
Open AccessMicrosurgical Treatment of Ethmoidal Dural Arteriovenous Fistula
- 21 November 2024
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97  (1) , 112-119
Safety and Efficacy of Tiny (≤3 mm) Unruptured Middle Cerebral Artery Aneurysm Treatment: An Analysis of the NeuroVascular Quality Initiative-Quality Outcomes Database Cerebral Aneurysm Registry
BACKGROUND AND OBJECTIVES: Improved imaging modalities have led to an increased detection of intracranial aneurysms, many of which are small. There is uncertainty in the appropriate management of tiny aneurysms. The objective of this study was to use a large, multi-institutional NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) to assess the frequency, safety, and efficacy of treatment of tiny, unruptured middle cerebral artery (MCA) aneurysms. METHODS: The NeuroVascular Quality Initiative-Quality Outcomes Database registry was queried for patients with tiny unruptured MCA aneurysms who underwent treatment. Tiny size was defined as an aneurysm with a maximum dimension of ≤3 mm. Demographics, aneurysm characteristics, and treatment safety were queried. Outcomes included modified Rankin Score (mRS) at discharge and the last follow-up as well as aneurysm occlusion status at discharge. RESULTS: Of 674 treated, unruptured MCA aneurysms, 57 (8.5%) were tiny. The mean aneurysm width was 2.2 mm, and the mean patient age was 55.9 years. Most aneurysms were treated with microsurgery (61.4%, 35/57). The overall intraoperative complication rate was 5.3% (3/57), and the postoperative complication rate was 10.5% (6/57). 10.5% (6/57) of patients were discharged to rehabilitation. At discharge, 42 (87.5%) of the treated aneurysms had complete occlusion. In the subgroup of patients with recorded follow-up data, 48.3% (14/29) had a mRS of 0 at discharge and 46.9% (15/32) had an mRS of 0 at the last follow-up (median follow-up 166 days). CONCLUSION: Treatment of tiny, unruptured MCA aneurysms is efficacious but may have a high rate of complications. Physicians should be cautious when deciding to treat tiny, unruptured MCA aneurysms.
- 21 November 2024
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97  (1) , 112-119
Safety and Efficacy of Tiny (≤3 mm) Unruptured Middle Cerebral Artery Aneurysm Treatment: An Analysis of the NeuroVascular Quality Initiative-Quality Outcomes Database Cerebral Aneurysm Registry
BACKGROUND AND OBJECTIVES: Improved imaging modalities have led to an increased detection of intracranial aneurysms, many of which are small. There is uncertainty in the appropriate management of tiny aneurysms. The objective of this study was to use a large, multi-institutional NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) to assess the frequency, safety, and efficacy of treatment of tiny, unruptured middle cerebral artery (MCA) aneurysms. METHODS: The NeuroVascular Quality Initiative-Quality Outcomes Database registry was queried for patients with tiny unruptured MCA aneurysms who underwent treatment. Tiny size was defined as an aneurysm with a maximum dimension of ≤3 mm. Demographics, aneurysm characteristics, and treatment safety were queried. Outcomes included modified Rankin Score (mRS) at discharge and the last follow-up as well as aneurysm occlusion status at discharge. RESULTS: Of 674 treated, unruptured MCA aneurysms, 57 (8.5%) were tiny. The mean aneurysm width was 2.2 mm, and the mean patient age was 55.9 years. Most aneurysms were treated with microsurgery (61.4%, 35/57). The overall intraoperative complication rate was 5.3% (3/57), and the postoperative complication rate was 10.5% (6/57). 10.5% (6/57) of patients were discharged to rehabilitation. At discharge, 42 (87.5%) of the treated aneurysms had complete occlusion. In the subgroup of patients with recorded follow-up data, 48.3% (14/29) had a mRS of 0 at discharge and 46.9% (15/32) had an mRS of 0 at the last follow-up (median follow-up 166 days). CONCLUSION: Treatment of tiny, unruptured MCA aneurysms is efficacious but may have a high rate of complications. Physicians should be cautious when deciding to treat tiny, unruptured MCA aneurysms.
- 1 April 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. -1  (aop) , 1
Letter to the Editor. The history of the well-traveled aneurysm clips
"Letter to the Editor. The history of the well-traveled aneurysm clips" published on 26 Apr 2024 by American Association of Neurological Surgeons.
- 1 April 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. -1  (aop) , 1
Letter to the Editor. The history of the well-traveled aneurysm clips
"Letter to the Editor. The history of the well-traveled aneurysm clips" published on 26 Apr 2024 by American Association of Neurological Surgeons.
- 25 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e203-e213
Role of Indocyanine Green with FLOW 800 in Removal of Hidden Arteriovenous Malformations
- 25 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e203-e213
Role of Indocyanine Green with FLOW 800 in Removal of Hidden Arteriovenous Malformations
- Open Access
- 25 February 2022
- Published by Springer Nature in Cureus
- Vol. 14  (2) , e22605
Acute Calcific Cerebral Embolism Large Vessel Occlusion: A Unique Stroke Mechanism With Hard Challenges
We present the case of an ischemic stroke associated with partially occlusive acute calcified cerebral emboli large vessel occlusion (CCE LVO). No revascularization strategy guidelines have been established for this unique acute ischemic stroke population, although many studies have reported impaired and inconsistent responses to both thrombolysis and thrombectomy. The patient in this case report, unfortunately, experienced a failed attempt at complete thrombolysis, resulting in a poor clinical outcome. Endovascular thrombectomy was not performed because of incomplete obstruction and risk of injury. Follow-up imaging revealed an acute ischemic stroke at the large middle cerebral artery and a new intraparenchymal hemorrhage with complete absence of the previously identified calcified embolus. This case and current literature demonstrate that more data are needed to determine the best revascularization approach for patients with CCE LVO stroke. With tissue plasminogen activator marginally effective in these patients, thrombectomy should be considered in highly unstable, clinically symptomatic patients even only with partial vessel occlusion.
- 25 February 2022
- Published by Springer Nature in Cureus
- Vol. 14  (2) , e22605
Open AccessAcute Calcific Cerebral Embolism Large Vessel Occlusion: A Unique Stroke Mechanism With Hard Challenges
We present the case of an ischemic stroke associated with partially occlusive acute calcified cerebral emboli large vessel occlusion (CCE LVO). No revascularization strategy guidelines have been established for this unique acute ischemic stroke population, although many studies have reported impaired and inconsistent responses to both thrombolysis and thrombectomy. The patient in this case report, unfortunately, experienced a failed attempt at complete thrombolysis, resulting in a poor clinical outcome. Endovascular thrombectomy was not performed because of incomplete obstruction and risk of injury. Follow-up imaging revealed an acute ischemic stroke at the large middle cerebral artery and a new intraparenchymal hemorrhage with complete absence of the previously identified calcified embolus. This case and current literature demonstrate that more data are needed to determine the best revascularization approach for patients with CCE LVO stroke. With tissue plasminogen activator marginally effective in these patients, thrombectomy should be considered in highly unstable, clinically symptomatic patients even only with partial vessel occlusion.
- 1 December 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 211, 107032
Management of neurophysiological monitoring changes during carotid endarterectomy exposure
- 1 December 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 211, 107032
Management of neurophysiological monitoring changes during carotid endarterectomy exposure
- 29 November 2021
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22  (1) , e35-e36
Commentary: Comparative Anatomical Assessment of Full vs Limited Transcavernous Exposure of the Carotid-Oculomotor Window
- 29 November 2021
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22  (1) , e35-e36
Commentary: Comparative Anatomical Assessment of Full vs Limited Transcavernous Exposure of the Carotid-Oculomotor Window